1. Home
  2. ALMS vs NXJ Comparison

ALMS vs NXJ Comparison

Compare ALMS & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • NXJ
  • Stock Information
  • Founded
  • ALMS 2021
  • NXJ 1999
  • Country
  • ALMS United States
  • NXJ United States
  • Employees
  • ALMS N/A
  • NXJ N/A
  • Industry
  • ALMS
  • NXJ Finance/Investors Services
  • Sector
  • ALMS
  • NXJ Finance
  • Exchange
  • ALMS NYSE
  • NXJ Nasdaq
  • Market Cap
  • ALMS 402.6M
  • NXJ 467.2M
  • IPO Year
  • ALMS 2024
  • NXJ N/A
  • Fundamental
  • Price
  • ALMS $3.29
  • NXJ $11.33
  • Analyst Decision
  • ALMS Strong Buy
  • NXJ
  • Analyst Count
  • ALMS 7
  • NXJ 0
  • Target Price
  • ALMS $26.83
  • NXJ N/A
  • AVG Volume (30 Days)
  • ALMS 1.1M
  • NXJ 74.9K
  • Earning Date
  • ALMS 05-14-2025
  • NXJ 01-01-0001
  • Dividend Yield
  • ALMS N/A
  • NXJ 3.27%
  • EPS Growth
  • ALMS N/A
  • NXJ N/A
  • EPS
  • ALMS N/A
  • NXJ N/A
  • Revenue
  • ALMS $17,389,000.00
  • NXJ N/A
  • Revenue This Year
  • ALMS N/A
  • NXJ N/A
  • Revenue Next Year
  • ALMS N/A
  • NXJ N/A
  • P/E Ratio
  • ALMS N/A
  • NXJ N/A
  • Revenue Growth
  • ALMS N/A
  • NXJ N/A
  • 52 Week Low
  • ALMS $3.18
  • NXJ $10.06
  • 52 Week High
  • ALMS $13.53
  • NXJ $12.24
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • NXJ 43.69
  • Support Level
  • ALMS N/A
  • NXJ $11.28
  • Resistance Level
  • ALMS N/A
  • NXJ $11.39
  • Average True Range (ATR)
  • ALMS 0.00
  • NXJ 0.09
  • MACD
  • ALMS 0.00
  • NXJ 0.00
  • Stochastic Oscillator
  • ALMS 0.00
  • NXJ 29.17

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

Share on Social Networks: